• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学和单细胞测序揭示了低Ki-67三阴性乳腺癌的特定生物学特征。

Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer.

作者信息

Han Boyue, Han Xiangchen, Luo Hong, Nasir Javaria, Chen Chao, Shao Zhiming, Ling Hong, Hu Xin

机构信息

Key Laboratory of Breast Cancer in Shanghai, Department of Breast Surgery Fudan University Shanghai Cancer Center Shanghai China.

Department of Oncology Shanghai Medical College, Fudan University Shanghai China.

出版信息

Cancer Innov. 2024 Sep 19;3(5):e146. doi: 10.1002/cai2.146. eCollection 2024 Oct.

DOI:10.1002/cai2.146
PMID:39301202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411700/
Abstract

BACKGROUND

Triple-negative breast cancer (TNBC) displays high heterogeneity. The majority of TNBC cases are characterized by high Ki-67 expression. TNBC with low Ki-67 expression accounts for only a small fraction of cases and has been relatively less studied.

METHODS

This study analyzed a large single-center multiomics TNBC data set, combined with a single-cell data set. The clinical, genomic, and metabolic characteristics of patients with low Ki-67 TNBC were analyzed.

RESULTS

The clinical and pathological characteristics were analyzed in 2217 TNBC patients. Low Ki-67 TNBC was associated with a higher patient age at diagnosis, a lower proportion of invasive ductal carcinoma, increased alterations in the PI3K-AKT-mTOR pathway, upregulated lipid metabolism pathways, and enhanced infiltration of M2 macrophages. High Ki-67 TNBC exhibited a higher prevalence of TP53 gene mutations, elevated nucleotide metabolism, and increased infiltration of M1 macrophages.

CONCLUSIONS

We identified specific genomic and metabolic characteristics unique to low Ki-67 TNBC, which have implications for the development of precision therapies and patient stratification strategies.

摘要

背景

三阴性乳腺癌(TNBC)具有高度异质性。大多数TNBC病例的特征是Ki-67表达高。Ki-67表达低的TNBC病例仅占一小部分,且相关研究相对较少。

方法

本研究分析了一个大型单中心多组学TNBC数据集,并结合了一个单细胞数据集。分析了Ki-67低表达TNBC患者的临床、基因组和代谢特征。

结果

对2217例TNBC患者的临床和病理特征进行了分析。Ki-67低表达的TNBC与诊断时患者年龄较大、浸润性导管癌比例较低、PI3K-AKT-mTOR通路改变增加、脂质代谢途径上调以及M2巨噬细胞浸润增强有关。Ki-67高表达的TNBC表现出TP53基因突变的较高发生率、核苷酸代谢升高以及M1巨噬细胞浸润增加。

结论

我们确定了Ki-67低表达TNBC特有的特定基因组和代谢特征,这对精准治疗的开发和患者分层策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/60203883f116/CAI2-3-e146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/be5b7105e0c7/CAI2-3-e146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/e197efc1cb77/CAI2-3-e146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/2bcbbb283753/CAI2-3-e146-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/111cf397933f/CAI2-3-e146-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/87f0fa118ccc/CAI2-3-e146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/60203883f116/CAI2-3-e146-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/be5b7105e0c7/CAI2-3-e146-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/e197efc1cb77/CAI2-3-e146-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/2bcbbb283753/CAI2-3-e146-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/111cf397933f/CAI2-3-e146-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/87f0fa118ccc/CAI2-3-e146-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3fd/11411700/60203883f116/CAI2-3-e146-g001.jpg

相似文献

1
Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer.多组学和单细胞测序揭示了低Ki-67三阴性乳腺癌的特定生物学特征。
Cancer Innov. 2024 Sep 19;3(5):e146. doi: 10.1002/cai2.146. eCollection 2024 Oct.
2
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.对年轻和老年三阴性乳腺癌患者进行综合分子谱分析表明存在不同的生物学基础和临床管理策略。
Cancer. 2020 Jul 15;126(14):3209-3218. doi: 10.1002/cncr.32922. Epub 2020 May 8.
3
Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.Claudin 4在三阴性乳腺癌中的表达:与雄激素受体及Ki-67表达的相关性
Ann Diagn Pathol. 2015 Feb;19(1):37-42. doi: 10.1016/j.anndiagpath.2014.10.003. Epub 2014 Oct 25.
4
Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer.检测摩洛哥三阴性乳腺癌患者的 PIK3/AKT 通路。
BMC Cancer. 2018 Sep 18;18(1):900. doi: 10.1186/s12885-018-4811-x.
5
Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.Hsa_circ_0000199 通过干扰 miR-206/613 介导的 PI3K/Akt/mTOR 信号通路促进三阴性乳腺癌的化疗耐受。
Aging (Albany NY). 2021 Jan 20;13(3):4522-4551. doi: 10.18632/aging.202415.
6
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.与三阴性乳腺癌相关的微腺性腺病是一种具有TP53体细胞突变的三阴性表型肿瘤性病变。
J Pathol. 2016 Apr;238(5):677-88. doi: 10.1002/path.4691.
7
Distinct Somatic Alteration Features Identified by Gene Panel Sequencing in Korean Triple-Negative Breast Cancer with High Ki67 Expression.通过基因panel测序在韩国高Ki67表达三阴性乳腺癌中鉴定出的独特体细胞改变特征
Diagnostics (Basel). 2021 Mar 1;11(3):416. doi: 10.3390/diagnostics11030416.
8
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.三阴性乳腺癌中 PI3K/AKT/mTOR 通路的靶向治疗:综述。
Breast Cancer Res Treat. 2018 Jun;169(3):397-406. doi: 10.1007/s10549-018-4697-y. Epub 2018 Feb 7.
9
Essential amino acid metabolism-related molecular classification in triple-negative breast cancer.三阴性乳腺癌中必需氨基酸代谢相关的分子分类
Epigenomics. 2021 Aug;13(16):1247-1268. doi: 10.2217/epi-2021-0210. Epub 2021 Aug 27.
10
The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.在小鼠三阴性乳腺癌模型中,链球菌毒力蛋白PepO通过重编程肿瘤相关巨噬细胞来触发抗肿瘤免疫反应。
Cell Biosci. 2023 Nov 4;13(1):198. doi: 10.1186/s13578-023-01153-w.

本文引用的文献

1
Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From -Infected Dendritic Cells in Mice Colorectal Cancer.感染小鼠树突状细胞来源的外泌体在结直肠癌中的抗肿瘤作用及作用机制
Front Oncol. 2022 Apr 22;12:870528. doi: 10.3389/fonc.2022.870528. eCollection 2022.
2
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.三阴性低Ki-67增殖(TNLP)乳腺癌的临床病理特征及对新辅助化疗的反应
NPJ Breast Cancer. 2022 Apr 20;8(1):51. doi: 10.1038/s41523-022-00415-z.
3
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.
乳腺癌中的巨噬细胞生物学和免疫抑制机制。
Front Immunol. 2021 Apr 23;12:643771. doi: 10.3389/fimmu.2021.643771. eCollection 2021.
4
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.抗 PD-1 治疗乳腺癌患者瘤内变化的单细胞图谱。
Nat Med. 2021 May;27(5):820-832. doi: 10.1038/s41591-021-01323-8. Epub 2021 May 6.
5
Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.基于代谢途径的三阴性乳腺癌分型揭示潜在的治疗靶点。
Cell Metab. 2021 Jan 5;33(1):51-64.e9. doi: 10.1016/j.cmet.2020.10.012. Epub 2020 Nov 11.
6
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.单细胞 RNA-seq 和批量 RNA-seq 的综合分析揭示了三阴性乳腺癌中的肿瘤异质性以及 M2 样肿瘤相关巨噬细胞浸润和侵袭性。
Cancer Immunol Immunother. 2021 Jan;70(1):189-202. doi: 10.1007/s00262-020-02669-7. Epub 2020 Jul 17.
7
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes.乳腺多形性腺瘤和黏液表皮样癌由融合基因支持。
NPJ Breast Cancer. 2020 Jun 5;6:20. doi: 10.1038/s41523-020-0164-0. eCollection 2020.
8
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR Metastatic Triple-Negative Breast Cancer.TBCRC 032IB/II 多中心研究:AR 拮抗剂和 PI3K 抑制剂对 AR 转移性三阴性乳腺癌患者疗效的分子见解。
Clin Cancer Res. 2020 May 1;26(9):2111-2123. doi: 10.1158/1078-0432.CCR-19-2170. Epub 2019 Dec 10.
9
Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis.Ki-67在三阴性乳腺癌切除患者中的预后价值:一项荟萃分析。
Front Oncol. 2019 Oct 17;9:1068. doi: 10.3389/fonc.2019.01068. eCollection 2019.
10
Determining cell type abundance and expression from bulk tissues with digital cytometry.利用数字细胞术从组织样本中测定细胞类型丰度和表达。
Nat Biotechnol. 2019 Jul;37(7):773-782. doi: 10.1038/s41587-019-0114-2. Epub 2019 May 6.